Showing results (361-370 of 459) with videos related to

Sort By:
Pageof 46
Arthritis & Rheumatology (Hoboken, N.J.)|May 27, 2021
Neuropsychiatric Events in Systemic Lupus Erythematosus: Predictors of Occurrence and Resolution in a Longitudinal Analysis of an International Inception CohortJohn G Hanly, Caroline Gordon, Sang-Cheol Bae, et al.
The Journal of Clinical Investigation|March 25, 2009
Kallikrein genes are associated with lupus and glomerular basement membrane-specific antibody-induced nephritis in mice and humansKui Liu, Quan-Zhen Li, Angelica M Delgado-Vega, et al.
Lupus Science & Medicine|November 11, 2025
Impact of glucocorticoid dose threshold in definition of lupus low disease activity state: a multinational observational cohort studyRangi Kandane-Rathnayake, Alberta Hoi, Worawit Louthrenoo, et al.
Arthritis Research & Therapy|July 23, 2025
Prevalence and outcomes of a pilot definition of severe refractory systemic lupus erythematosus: observations from a multinational Asia-Pacific cohortRangi Kandane-Rathnayake, Worawit Louthrenoo, C S Lau, et al.
Rheumatology International|February 7, 2016
Mapping health assessment questionnaire disability index (HAQ-DI) score, pain visual analog scale (VAS), and disease activity score in 28 joints (DAS28) onto the EuroQol-5D (EQ-5D) utility score with the KORean Observational study Network for Arthritis (KORONA) registry dataHye-Lin Kim, Dam Kim, Eun Jin Jang, et al.
Annals of the Rheumatic Diseases|January 10, 2020
Neuropsychiatric events in systemic lupus erythematosus: a longitudinal analysis of outcomes in an international inception cohort using a multistate model approachJohn G Hanly, Murray B Urowitz, Caroline Gordon, et al.
Rheumatology (Oxford, England)|December 10, 2024
Association of lupus low disease activity state and remission with reduced organ damage and flare in systemic lupus erythematosus patients with high disease activity: a multi-national, longitudinal cohort studyRangi Kandane-Rathnayake, Vera Golder, Worawit Louthrenoo, et al.
The Lancet. Rheumatology|January 22, 2024
Impact of low disease activity, remission, and complete remission on flares following tapering of corticosteroids and immunosuppressive therapy in patients with systemic lupus erythematous: a multinational cohort studyJiacai Cho, Liang Shen, Molla Huq, et al.
The Journal of Rheumatology|March 15, 2024
Comparison of Attainment and Protective Effects of Lupus Low Disease Activity State in Patients With Newly Diagnosed Versus Established Systemic Lupus ErythematosusVera Golder, Rangi Kandane-Rathnayake, Worawit Louthrenoo, et al.
Journal of Biomedicine & Biotechnology|August 14, 2010
The role of genetic variation near interferon-kappa in systemic lupus erythematosusIsaac T W Harley, Timothy B Niewold, Rebecca M Stormont, et al.
Pageof 46